insights

Scientists also wanted to know if these mutations indicated a possible reduction in the effectiveness of the COVID-19 vaccines and certain monoclonal antibody treatments. Antibodies such a rituximab, ofatumumab and alemtuzumab which target lymphomas directly rely mainly on FcR-expressing myeloid cells to deliver their killing activity. It is known that […]